OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports
Go back to OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports| Phazar Corp (NASDAQ: ANTP) | Delayed: 1.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $2.75 | |||
| Open | $1.25 | 52 Week Low | $1.10 | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $-1.58 | |||
| Volume | 105,496 | |||||
| (NASDAQ: OBIO) | Delayed: 5.82 +0.17 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.65 | 52 Week High | $ | |||
| Open | $5.65 | 52 Week Low | $ | |||
| Day High | $6.17 | P/E | N/A | |||
| Day Low | $5.53 | EPS | $ | |||
| Volume | 986,897 | |||||



